Galectin Therapeutics Inc. (GALT)

NASDAQ: GALT · Real-Time Price · USD

1.260

+0.040 (3.28%)

At close: Apr 1, 2025, 4:00 PM

1.282

+0.022 (1.72%)

After-hours: Apr 1, 2025, 5:03 PM EDT

Galectin Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Selling, General & Admin	5.86	5.94	6.62	6.36	5.47	Upgrade
Research & Development	36.57	32.13	31.74	23.82	17.98	Upgrade
Operating Expenses	42.43	38.07	38.35	30.18	23.44	Upgrade
Operating Income	-42.43	-38.07	-38.35	-30.18	-23.44	Upgrade
Interest Expense	-5.54	-2.79	-1.03	-0.49	-0.09	Upgrade
Interest & Investment Income	0.34	0.23	0.05	0	0.07	Upgrade
Other Non Operating Income (Expenses)	0.59	-0.43	0.56	0.14	-	Upgrade
EBT Excluding Unusual Items	-47.05	-41.07	-38.78	-30.53	-23.47	Upgrade
Pretax Income	-47.05	-41.07	-38.78	-30.53	-23.47	Upgrade
Net Income	-47.05	-41.07	-38.78	-30.53	-23.47	Upgrade
Preferred Dividends & Other Adjustments	0.15	3.74	0.1	0.17	0.14	Upgrade
Net Income to Common	-47.2	-44.81	-38.87	-30.7	-23.6	Upgrade
Shares Outstanding (Basic)	62	60	59	59	57	Upgrade
Shares Outstanding (Diluted)	62	60	59	59	57	Upgrade
Shares Change (YoY)	3.57%	1.29%	1.48%	2.63%	9.17%	Upgrade
EPS (Basic)	-0.76	-0.74	-0.65	-0.52	-0.41	Upgrade
EPS (Diluted)	-0.76	-0.74	-0.65	-0.52	-0.41	Upgrade
EBIT	-42.43	-38.07	-38.35	-30.18	-23.44	Upgrade

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q